Prognostic factors for local and distant control in Ewing sarcoma family of tumors

Annals of Oncology

Volumn 19, Issue 4, 2008, Pages 814-820

  Rodríguez Galindo, Carlos ^a   Navid, F ^a   Liu, T ^a   Billups, C A ^a   Rao, B N ^a   Krasin, M J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Distant recurrence; Ewing sarcoma; Local recurrence; Pediatric cancer

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG MEGADOSE; EWING SARCOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 41549114518     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm521     Document Type: Article

References (29)

1. Gurney JG, Swensen AR, Bulterys M. Malignant bone tumors. In Ries LAG et al. (eds): Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. 1999; 99-110.
2. Marina NM, Pappo AS, Parham DM et al. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round cell tumor: A feasibility study at St. Jude Children's Research Hospital. J Clin Oncol 1999; 17: 180-190.
3. Craft AW, Paulussen M, Douglas C et al. EICESS 92 - early results of an international Ewings tumour study. Med Pediatr Oncol 2000; 35: 191.
4. Rodriguez-Galindo C, Spunt SL, Pappo AS. Treatment of Ewing sarcoma family of tumors: Current status and outlook for the future. Med Pediatr Oncol 2003; 40: 276-287.
5. Hayes FA, Thompson EI, Meyer WH et al. Therapy for localized Ewing's sarcoma of bone. J Clin Oncol 1989; 7: 208-213.
6. Meyer WH, Kun L, Marina N et al. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of the bone. J Clin Oncol 1992; 10: 1737-1742.
7. Cranowetter L, Womer R, Devidas M et al. Comparison of dose intensified and standard dose chemotherapy for the treatment of non-metastatic Ewing's sarcoma (ES) and primitive neuroectodermal tumor (PNET) of bone and soft tissue: A Pediatric Oncology Group-Children's Cancer Group phase III trial. Med Pediatr Oncol 2001; 37: 172 (Abstr 038).
8. Navid F, Santana VM, Billups CA et al. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas. Cancer 2006; 106: 1846-1856.
9. Kalbfleish JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons 1980.
10. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154.
11. Nesbit ME, Gehan EA, Burgert EO et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: A long-term follow-up of the first intergroup study. J Clin Oncol 1990; 8: 1664-1674.
12. Burgert EO, Nesbit ME, Garnsey LA et al. Multimodal therapy for the management of nonpelvic, localized-Ewing's sarcoma of bone: Intergroup Study IESS-II. J Clin Oncol 1990; 8: 1514-1524.
13. Craft AW, Cotterill SJ, Bullimore JA, Pearson D. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's. Cancer Study Group (UKCCSG)and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer 1997; 33: 1061-1069.
14. Donaldson SS, Torrey M, Link MP et al. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: End results at POG #8346. Int J Radiat Oncol Biol Phys 1998; 42: 125-135.
15. Rodriguez-Galindo G. Pharmacological management at Ewing sarcoma family of tumours. Expert Opin Pharmacother 2004; 5: 1257-1270.
16. Rodriguez-Galindo C, Liu T, Krasin MJ et al. Analysis of prognostc factors in Ewing sarcoma family of tumors: Review of St. Jude Children's Research Hospital studies. Cancer 2007; 110: 375-384.
17. Rodriguez-Galindo C, Billups CA, Kun LE et al. Survival after recurrence of Ewing tumors: The St Jude Children's Research Hospital experience, 1979-1999. Cancer 2002; 94: 561-569.
18. Schuck A, Ahrens S, Paulussen M et al. Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003; 55: 168-177.
19. Bacci G, Forni C. Longhi A et al. Long-term outcome for patients with nonmetastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 2004; 40: 73-83.
20. Krasin MJ, Rodriguez-Galindo C, Davidoff AM et al. Efficacy of combined surgery and irradiation for localized Ewings sarcoma family at tumors. Padiatr Blood Cancer 2004; 43: 229-236.
21. Shankar AG, Pinkerton CR, Atra A et al. Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG). Eur J Cancer 1999; 35: 1698-1704.
22. Dunst J, Sauer R, Burgers JM et al. Radiaiton therapy as local treatment in Ewing's sarcoma, Results of the Cooperative Ewing's Sarcoma Studies CESS 81 and CESS 86. Cancer 1991; 67: 2818-2825.
23. Merchant TE, Kushner BH, Sheldon JM et al. Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcoma. Med Pediatr Oncol 1999; 33: 65-70.
24. Krasin MJ, Davidoff AM, Rodriguez-Galindo C et al. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: Local outcome and prognostic factors. Cancer 2005; 104: 367-373.
25. Grier HE, Krailo MD, Tarbeli NJ et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348: 694-701.
26. Cotterill SJ, Ahrens S, Paulussen M et al, Prognostic factors in Ewing's tumor of bone: Analysis of 975 patients from the European Intergroup Cooperative Ewing"s Sarcoma Study Group. J Clin Oncol 2000; 18: 3108-3114.
27. Paulussen M, Ahrens S, Burdach S et al. Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies. Ann Oncol 1998; 9: 275-281.
28. Spunt SL, McCarville MB, Kun LE et al. Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis. J Pediatr Hematol Oncol 2001; 23: 93-98.
29. Schleiermacher G, Peter M, Oberlin O et al. Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing tumor. J Clin Oncol 2003; 21: 85-91.